Your browser doesn't support javascript.
loading
Comments on: Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis.
Wang, Yan; Sun, Xiu; Zhang, Junyan; Mei, Qi.
Affiliation
  • Wang Y; Department of Infection, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
  • Sun X; Department of Infection, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
  • Zhang J; Department of Clinical Epidemiology and Evidence-Based Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China. richard.zhang@both-win.net.
  • Mei Q; Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China. borismq@163.com.
Hepatol Int ; 18(2): 702-703, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38429497

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B, Chronic / Dyslipidemias Limits: Humans Language: En Journal: Hepatol Int / Hepatol. int. (Internet) / Hepatology international (Internet) Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B, Chronic / Dyslipidemias Limits: Humans Language: En Journal: Hepatol Int / Hepatol. int. (Internet) / Hepatology international (Internet) Year: 2024 Document type: Article Affiliation country: Country of publication: